Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Purpose:The aim of this study is to determine the intrathecal Bupivacaine concentration(0.5% vs 0.75%) with better anesthesia and little hemodynamic disturbance during cystoscopic procedures.In comparing these bupivacaine concentrations ,the result would be expected to enhance safer spinal anesthesia practices ,minimizing the use of vasopressors in urological surgeries.OBJECTIVE:To compare and analyze the frequency and average chages of post spinal hemodynamic instability in terms of hypotension and bradycardia with 0.75% hyperbaric bupivacaine and 0.55 hyperbaric bupivacaine in patients presenting for cystoscopic procedures.
OPERATIONAL DEFINITIONS:
Hemodynamic instability:This refers to systolic blood pressure heart rate shifts of 20% more or less from baseline value after spinal anesthesia.The hemodynamic instability will be evaluated both as a numerical change and categorical variable.
Hypotensin:A qualitative variable,defined as greater than 20% drop in baseline systolic blood pressure or systolic blood pressure of less than 90mmhg after spinal anesthesia.it will be recorded for each patient as present/absent.
Bradycardia:A qualitative variable,defined as heart rate below 60 beats per minute or greater than 20% drop in baseline heart rate after spinal anesthesia.it will be recorded for each patient as present /absent.
Hyperbaric bupivacaine:Local anesthetic mixed with dextrose to increase its density more than CSF.
0.75% hyperbaric bupivacaine is 7.5mg/ml. 0.5% hyperbaric bupivacaine is 5mg/ml. HYPOTHESIS:0.5% hyperbaric bupivacaine is better than 0.75% while undergoing cystoscopy under spinal anesthesia due to its better hemodynamic stability.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 0.5% hyperbaric bupivacaine group | Active Comparator | Patients will receive spinal anesthesia with 0.5% hyperbaric bupivacainefor cystoscopic procedures.hemodynamic parameters will be monitored and compared with other group. |
|
| 0.75% hyperbaric bupivacaine group | Active Comparator | Patients will receive spinal anesthesia with 0.75% hyperbaric bupivacaine for cystoscopic procedures.hemodynamic stability and related outcomes will be assesed and compared with 0.5% group. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 0.5% Hyperbaric Bupivicaine | Drug | 0.5% hyperbaric bupivacaine will be administered intrathecally for spinal anesthesia in patients undergoing cystoscopic procedures.hemodynamic parameters,systolic blood pressure and heart rate will be monitored, and its effects on hemodynamic stability will be assesed and compared with other intervention. |
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of frequency and mean changes in systolic blood pressure and heart rate | Measurement of frequency and mean changes in systolic blood pressure(to assess hypotension) and heart rate(to assess bradycardia)will be recorded and analyzed to evaluate the hemodynamic effects of 0.5% vs 0.75% hyperbaric bupivacaine in patients undergoing cystoscopic procedures under spinal anesthesia. | From institution of spinal block upto 30 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Requirement for Vasopressors, Atropine ,and Intravenous fluids | The need for vasopressors,atropine and iv fluids to manage hemodynamic instability during spinal anesthesia in patients undergoing cystoscopic procedures with 0.5% vs 0.75% hyperbaric bupivacaine shall also be recorded and compared. | From institution of spinal block upto 30 minutes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Known hypersensitivity to bupivacaine. Significant cardiovascular,hepatic or renal disease.
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dr Salbia Bibi, FCPS | Contact | +923330335004 | dr.salbia@yahoo.com |
| Name | Affiliation | Role |
|---|---|---|
| Dr Salbia Bibi, FCPS | PAEC General Hospital, Islamabad | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| PAEC General Hospital Islamabad | Islamabad | Punjab Province | 44000 | Pakistan |
As the hospital where this study is being conducted does not allow to share any collected data with other researches due to patient confidentiality.
Not provided
Not provided
Not provided
Not provided
Not provided
Study design:Randomized control trial(RCT).Setting:Department of anesthesia ,Pakistan Atomic Energy Commission General Hospital,Islamabad.
Duration:06 months(after approval of synopsis by CPSP)
Not provided
Not provided
Not provided
|
| 0.75% hyperbaric bupivacaine | Drug | 0.75% hyperbaric bupivacaine will be administered intrathecally duringspinal anesthesia in patients undergoing cystoscopic procedures.hemodynamic parameters will be monitored ,and its effects on hemodynamic stability will be assesed and compared with 0.5% bupivacaine. |
|